Research and Markets has announced the addition of the "FDA's Medical Device Software Regulation & Compliance: 2-Day In-Person Seminar by Ex-FDA Official" conference to their offering.

The seminar will be held at Boston, Massachusetts on August 25-26.

The professional healthcare provider and lay people rely more and more on the use of software. It pervades our lives. Likewise, the risks and vulnerabilities of software sneak into our lives. The use of software in medical devices or as a stand-alone product has outpaced the FDA’s ability to keep up with the technology.

Likewise, the industry has immersed itself in the development and use of software. The FDA’s regulatory approach has become increasingly stringent in terms of what software developers mush think about and validate. As software technology and its use become more complex and interdependent, the risks associated with problem accelerates and the correction or prevention of problem becomes almost impossible with different proprietary software. Likewise, firm’s must battle hackers. The federal government is using a peculiar approach to regulating software that affects what the FDA does. Software vulnerabilities and associated healthcare risks have a stronghold on patient care and lay use. The industry and the FDA find itself in a race to catch up with it.

For decades, software has been a leading cause for recalls, deaths and serious injuries. The FDA’s regulatory approach uses new premarket and post-market controls to try and reign in a problem that easily runs out of control.

The FBI has stated publicly that the healthcare industry and the FDA are the least prepared entities to respond to intentional software corruption. Hospitals' computer systems are routinely hacked, closed down and held ransom. Hackers can shut down a software based device from a remote location or plant malware that makes patient information public. What does your cybersecurity program cover? Manufacturers also create risks amongst themselves because their products are not inter-operable. Almost all hospitals have experienced this problem to one degree or another. Why would a firm buy your product when it is not compatible with other products it already uses? The federal government has forged new inroads into the problem. Firms must keep pace with the FDA’s demand for software information and design requirements.

Likewise, firms must learn how to apply Quality System regulation requirements successfully. Recalls and Medical Device Reports give you away. The current regulatory approach relies not just with the FDA, but in other areas of the federal government. You need to know and follow that evolution of current technology and applicable guidance. These are the kinds of issues that will be highlighted during the seminar.

Learning objectives are: FDA’s regulatory strategy, Pre-market and post-market controls, Interoperability, Voluntary standards, National Institute of Science and Technology, Mobile Apps, Professional and home use, Software recalls SHOW LESS.

For more information visit: http://www.researchandmarkets.com/research/k3sq5v/fdas_medical